Trials / Conditions / Urea Cycle Disorder

Urea Cycle Disorder

20 registered clinical trials studyying Urea Cycle Disorder — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	MyRareDiet A Novel Diet Tracking Tool NCT06664840	Oregon Health and Science University	N/A
Recruiting	Hepatic Histopathology in Urea Cycle Disorders NCT04908319	Baylor College of Medicine	—
Completed	Characterization of Intestinal Microbiota in Children With Inborn Errors of Metabolism (IEM) NCT05330039	Emma Marie Caroline Slack	—
Recruiting	Liver Disease in Urea Cycle Disorders NCT04612764	Baylor College of Medicine	—
Completed	Th1, Th2, Th17 Phenotype in Urea Cycle Disorders NCT05706714	Istanbul University - Cerrahpasa	—
Unknown	Dysregulated Urea-synthesis at Terminal Uremia NCT05076318	University of Aarhus	N/A
Recruiting	Systemic Biomarkers of Brain Injury From Hyperammonemia NCT04602325	Children's National Research Institute	—
Terminated	UNLOCKED: A Phase 2, Open-label Trial With KB195 in Subjects With a Urea Cycle Disorder NCT03933410	Kaleido Biosciences	Phase 2
Completed	Patient and Observer Reported Outcome Measurements in Inborn Errors of Metabolism NCT04248062	University Children's Hospital, Zurich	—
Withdrawn	A Safety and Efficacy Study of Infusions of HepaStem in Urea Cycle Disorders Pediatric Patients NCT03884959	HLB Cell Co., Ltd.	Phase 2
Terminated	HepaStem Long-Term Safety Registry NCT03343756	Cellaion SA	—
Completed	Study of Glycerol Phenylbutyrate & Sodium Phenylbutyrate in Phenylbutyrate Naïve Patients With Urea Cycle Diso NCT03335488	Amgen	Phase 4
Completed	Chronic Liver Disease in Urea Cycle Disorders NCT03721367	Baylor College of Medicine	—
Completed	Nitric Oxide Supplementation on Neurocognitive Functions in Patients With ASLD NCT03064048	Baylor College of Medicine	N/A
Completed	Safety and Tolerability of SYNB1020-CP-001 NCT03179878	Synlogic	Phase 1
Terminated	Manipulating the Gut Microbiome Study NCT03181828	Nicholas Ah Mew	Phase 1 / Phase 2
Completed	A Study of the Safety, Efficacy and Pharmacokinetics of Glycerol Phenylbutyrate in Pediatric Subjects Under 2 NCT02246218	Amgen	Phase 4
Terminated	Observational Study That Will Collect Information on Patients With Urea Cycle Disorders (UCDs) NCT01948427	Amgen	—
Completed	A Collection of Case Studies in Infants With UCD to Evaluate Infant Growth and the Safety of a New Medical Foo NCT03911089	Nutricia Research	N/A
Completed	Neurologic Injuries in Adults With Urea Cycle Disorders NCT00472732	Andrea Gropman	—